/
We are a vertically integrated health intelligence platform with a mission to power the behavior changes that drive better health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, AI built on that proprietary data, and a behavior change and coachi…
The business is unprofitable at the operating level (-163.94% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 17.3% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$26M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$21M
▼ -17.3% YoY
Net Income (TTM)
-$41M
▲ +2.4% YoY
Op. Margin
-163.06%
▲ +49.6pp YoY
ROIC
-27.57%
▲ +19.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$25M
▲ +32.6% YoY
Op. Cash Flow (TTM)
-$25M
▲ +32.7% YoY
Net Debt
$12M
Cash & Equiv.
$20M
5Y CAGR: +24.2%
Continue Research